Abstract
Epilepsy affects approximately 50 million people worldwide. Among them, at least 40 million people are currently living in the developing world, where resources and standards of care are suboptimal. Around 90 % of people with epilepsy in resource-poor countries do not currently receive appropriate treatments, at a time when two thirds of these patients could have achieved good control of their epileptic seizures had they had access to appropriate therapies. Scarcity of epilepsy specialists, poor availability or access to diagnostic facilities and treatments, poor community knowledge about epilepsy-related issues, stigma, and other societal and cultural barriers are only some of the issues contributing to this deficiency. These issues in epilepsy treatment have been well recognized, and ongoing concerted efforts to address them have been undertaken by both local authorities and international organizations. In many cases, patients resort to the use of traditional local and alternative medicines (herbs, religious practices, etc.) that are closer to indigenous cosmovision, are more holistic, and are more culture-friendly, preserving an optimum subtlety of Afrocentric character shading. Compared with imported Western medicines, patients find these approaches to be more relevant to their ways of thinking, their ways of being, and their belief systems, more accessible, and more acceptable methods of dealing with health and disease states. The impressive local wealth in these natural resources has established them as a preferred source of healing in these regions, but has also fueled interest in exploring their therapeutic potential in the very few existing local research centers. In this review, we discuss the known issues related to the epilepsy treatment gap in resource-poor regions, focusing in particular on African countries, introduce the role and issues related to the use and validation of alternative medical therapies in epilepsy, and comment on the importance and repercussions of initiatives to validate such therapies, primarily for local practices, but also for possible wider international applications.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
UN. World population 2012. 2012. http://www.un.org/en/development/desa/population/publications/pdf/trends/WPP2012_Wallchart.pdf. Accessed 25 Apr 2014.
Paul A, Adeloye D, George-Carey R, Kolcic I, Grant L, Chan KY. An estimate of the prevalence of epilepsy in sub-Saharan Africa: a systematic analysis. J Glob Health. 2012;2(2):020405.
World Health Organization, International Bureau of Epilepsy, International League Against Epilepsy. Atlas: epilepsy care in the world 2005. Geneva: Word Health Organization; 2005. p. 76-7. Available from: http://www.who.int/entity/mental_health/neurology/Epilepsy_atlas_r1.pdf.
The World Bank. Poverty data: a supplement to world development indicators 2008. Washington: International Bank for Reconstruction and Development/The World Bank; 2008.
World Health Organization, International Bureau of Epilepsy, International League Against Epilepsy. Atlas: epilepsy care in the world 2005. Geneva: Word Health Organization; 2005. Available from: http://www.who.int/entity/mental_health/neurology/Epilepsy_atlas_r1.pdf.
Diop AG, de Boer HM, Mandlhate C, Prilipko L, Meinardi H. The global campaign against epilepsy in Africa. Acta Trop. 2003;87(1):149–59.
World Health Organization. The global burden of disease: 2004 update. 2004. Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
Osuntokun BO, Adeuja AO, Nottidge VA, Bademosi O, Olumide A, Ige O, et al. Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia. 1987;28(3):272–9.
World Health Organization. Epilepsy in the WHO African region: bridging the gap. Geneva: World Health Organization; 2004.
Tekle-Haimanot R, Forsgren L, Ekstedt J. Incidence of epilepsy in rural central Ethiopia. Epilepsia. 1997;38(5):541–6.
Andermann L. Epilepsy in different cultures: epilepsy in developing countries. Epilepsy Aware. 1999;10(2).
Chabot J. The Bamako Initiative (letter). Lancet. 1988;2(8624):1366–7.
Wilmshurst JM, van der Walt JS, Ackermann S, Karlsson MO, Blockman M. Rescue therapy with high-dose oral phenobarbitone loading for refractory status epilepticus. J Paediatr Child Health. 2010;46(1–2):17–22.
Newton CR. Status epilepticus in resource-poor countries. Epilepsia. 2009;50 Suppl 12:54–5.
Amare A, Zenebe G, Hammack J, Davey G. Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Epilepsia. 2008;49(4):600–7.
Oshikoya KA, Senbanjo IO, Njokanma OF, Soipe A. Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complement Altern Med. 2008;8:66.
Quintans Junior LJ, Almeida JRGS, Lima JT, Nunes XP, Siqueira JS, Gomes de Oliveira LE, et al. Plants with anticonvulsant properties - a review. Bras J Pharmacogn. 2008;18(Suppl):798–819.
Tyagi A, Delanty N. Herbal remedies, dietary supplements, and seizures. Epilepsia. 2003;44(2):228–35.
van Wyk B-E, Gericke N. People’s plants. a guide to useful plants of southern Africa. Pretoria: Briza; 2000.
United Nations Environment Programme. Africa environment outlook 2 – our environment, our wealth (AEO-2). 2006.
Brendler T, Eloff JN, Gurib-Fakim A, Phillips D, editors. African herbal pharmacopoeia. 1st ed. Mauritius: Graphic; 2010.
Ntie-Kang F, Amoa Onguéné P, Fotso GW, Andrae-Marobela K, Bezabih M, Ndom JC, et al. Virtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants. PLoS One. 2014;9(3):e90655. doi:10.1371/journal.pone.0090655. eCollection 2014.
Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965–81.
Rates SM. Plants as source of drugs. Toxicon. 2001;39(5):603–13.
World Health Organization. WHO traditional medicine strategy 2002-2005. Geneva: World Health Organization; 2002.
Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001;109 Suppl 1:69–75.
Adesina SK, Ette EI. The isolation and identification of anticonvulsant agents from Clausena anisata and Afraegle paniculata. Fitoterapia. 1982;53:63–6.
Owolabi MO, Bower JH, Ogunniyi A. Mapping Africa's way into prominence in the field of neurology. Arch Neurol. 2007;64(12):1696–700.
Birx D, de Souza M, Nkengasong JN. Laboratory challenges in the scaling up of HIV, TB, and malaria programs: the interaction of health and laboratory systems, clinical research, and service delivery. Am J Clin Pathol. 2009;131(6):849–51.
Berhan Y. Medical doctors profile in Ethiopia: production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium. Ethiop Med J. 2008;46 Suppl 1:1–77.
Mills EJ, Kanters S, Hagopian A, Bansback N, Nachega J, Alberton M, et al. The financial cost of doctors emigrating from sub-Saharan Africa: human capital analysis. BMJ. 2011;343:d7031.
The Natural Product Research Network for Eastern and Central Africa (NAPRECA). Natural Products and Drug Discovery. The 11th symposium of the National Product Research Network for Eastern and Central Africa (NAPRECA); 2005; Antananarivo.
Zumla A, Huggett J, Dheda K, Green C, Kapata N, Mwaba P. Trials and tribulations of an African-led research and capacity development programme: the case for EDCTP investments. Trop Med Int Health. 2010;15(4):489–94.
Chu KM, Jayaraman S, Kyamanywa P, Ntakiyiruta G. Building research capacity in Africa: equity and global health collaborations. PLoS Med. 2014;11(3):e1001612.
Bum EN, Taiwe GS, Nkainsa LA, Moto FC, Seke Etet PF, Hiana IR, et al. Validation of anticonvulsant and sedative activity of six medicinal plants. Epilepsy Behav. 2009;14(3):454–8.
Dhawan BN, Patnaik GK, Rastogi RP, Singh KK, Tandon JS. Screening of Indian plants for biological activity: part VI. Indian J Exp Biol. 1977;15(3):208–19.
Jager AK, Mohoto SP, van Heerden FR, Viljoen AM. Activity of a traditional South African epilepsy remedy in the GABA-benzodiazepine receptor assay. J Ethnopharmacol. 2005;96(3):603–6.
Compliance with Ethics Guidelines
Conflict of Interest
Yohannes W. Woldeamanuel and Belaineh Girma declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Epilepsy
Rights and permissions
About this article
Cite this article
Woldeamanuel, Y.W., Girma, B. Contributing Towards the Betterment of Translational Epilepsy Research in Africa: Needs, Challenges, Resources, and Opportunities. Curr Neurol Neurosci Rep 14, 480 (2014). https://doi.org/10.1007/s11910-014-0480-6
Published:
DOI: https://doi.org/10.1007/s11910-014-0480-6